Cincinnati Children’s

Enable Injections designs and manufactures wearable devices that deliver injectable drugs directly into the subcutaneous tissue. The system accepts standard vials, syringes, or cartridges, automatically reconstitutes lyophilized solutions, warms the drug, and injects high‑viscosity or high‑volume payloads up to 20 ml. Users place the device on the skin, press a central button, and monitor delivery progress through a viewing window before disposing of the single‑use injector. The company also offers transfer systems for partial or multi‑vial filling and a Bluetooth‑enabled version that can connect to smartphones. Founded in 2010, the company is headquartered in Cincinnati, Ohio, and targets a growing market for self‑administration of biologics and other therapeutics.

Airway Therapeutics, Inc. is a biopharmaceutical company focused on developing protein therapeutics for lung and pediatric applications. Founded in 2008 and headquartered in Cincinnati, Ohio, with an additional office in Marietta, Georgia, the company is engaged in licensing technology from the pulmonary research program of Cincinnati Children's Hospital Medical Center to enhance its development platform. Airway Therapeutics' key products include recombinant human surfactant protein-D, aimed at preventing bronchopulmonary dysplasia in premature infants, and AT100, a protein replacement therapy for the same condition. The company is dedicated to addressing various market needs related to respiratory and inflammatory diseases by creating innovative biologics that reduce inflammation, lower infection risks, and modulate the immune response, ultimately improving treatment outcomes for patients.

Enable Injections designs and manufactures wearable devices that deliver injectable drugs directly into the subcutaneous tissue. The system accepts standard vials, syringes, or cartridges, automatically reconstitutes lyophilized solutions, warms the drug, and injects high‑viscosity or high‑volume payloads up to 20 ml. Users place the device on the skin, press a central button, and monitor delivery progress through a viewing window before disposing of the single‑use injector. The company also offers transfer systems for partial or multi‑vial filling and a Bluetooth‑enabled version that can connect to smartphones. Founded in 2010, the company is headquartered in Cincinnati, Ohio, and targets a growing market for self‑administration of biologics and other therapeutics.

Airway Therapeutics, Inc. is a biopharmaceutical company focused on developing protein therapeutics for lung and pediatric applications. Founded in 2008 and headquartered in Cincinnati, Ohio, with an additional office in Marietta, Georgia, the company is engaged in licensing technology from the pulmonary research program of Cincinnati Children's Hospital Medical Center to enhance its development platform. Airway Therapeutics' key products include recombinant human surfactant protein-D, aimed at preventing bronchopulmonary dysplasia in premature infants, and AT100, a protein replacement therapy for the same condition. The company is dedicated to addressing various market needs related to respiratory and inflammatory diseases by creating innovative biologics that reduce inflammation, lower infection risks, and modulate the immune response, ultimately improving treatment outcomes for patients.

Airway Therapeutics, Inc. is a biopharmaceutical company focused on developing protein therapeutics for lung and pediatric applications. Founded in 2008 and headquartered in Cincinnati, Ohio, with an additional office in Marietta, Georgia, the company is engaged in licensing technology from the pulmonary research program of Cincinnati Children's Hospital Medical Center to enhance its development platform. Airway Therapeutics' key products include recombinant human surfactant protein-D, aimed at preventing bronchopulmonary dysplasia in premature infants, and AT100, a protein replacement therapy for the same condition. The company is dedicated to addressing various market needs related to respiratory and inflammatory diseases by creating innovative biologics that reduce inflammation, lower infection risks, and modulate the immune response, ultimately improving treatment outcomes for patients.

Enable Injections designs and manufactures wearable devices that deliver injectable drugs directly into the subcutaneous tissue. The system accepts standard vials, syringes, or cartridges, automatically reconstitutes lyophilized solutions, warms the drug, and injects high‑viscosity or high‑volume payloads up to 20 ml. Users place the device on the skin, press a central button, and monitor delivery progress through a viewing window before disposing of the single‑use injector. The company also offers transfer systems for partial or multi‑vial filling and a Bluetooth‑enabled version that can connect to smartphones. Founded in 2010, the company is headquartered in Cincinnati, Ohio, and targets a growing market for self‑administration of biologics and other therapeutics.

Assurex Health specializes in personalized medicine, assisting clinicians in determining optimal medications for individual patients with behavioral health and chronic pain conditions. They provide treatment decision support to healthcare providers.

Airway Therapeutics, Inc. is a biopharmaceutical company focused on developing protein therapeutics for lung and pediatric applications. Founded in 2008 and headquartered in Cincinnati, Ohio, with an additional office in Marietta, Georgia, the company is engaged in licensing technology from the pulmonary research program of Cincinnati Children's Hospital Medical Center to enhance its development platform. Airway Therapeutics' key products include recombinant human surfactant protein-D, aimed at preventing bronchopulmonary dysplasia in premature infants, and AT100, a protein replacement therapy for the same condition. The company is dedicated to addressing various market needs related to respiratory and inflammatory diseases by creating innovative biologics that reduce inflammation, lower infection risks, and modulate the immune response, ultimately improving treatment outcomes for patients.

Assurex Health specializes in personalized medicine, assisting clinicians in determining optimal medications for individual patients with behavioral health and chronic pain conditions. They provide treatment decision support to healthcare providers.